A rapid microtitre plate screening method for in vitro assessment of fibrinolysis: a preliminary report.
A novel and precise assay that facilitates high-throughput screening of fibrinolytic agents was developed based on the automated assessment of the euglobulin clot lysis time in microtitre plates. Euglobulin fractions from fresh plasma samples were assessed over 28 days to determine the inter-assay and intra-assay precision. The intra-assay (coefficient of variation range, 0.7-2.6%) and inter-assay precision (coefficient of variation range, 6.8-12.1%) was found to be well within limits required by the Food and Drug Administration. On day 1 and day 28, the results of the microtitre plate euglobulin clot lysis time method were compared with tissue plasminogen activator activity, plasminogen activator inhibitor activity and results produced on fibrin plates. All comparisons were found to correlate significantly. The validity of this method for assaying fibrinolytic agents was assessed by comparing dose-response curves for streptokinase produced using fibrin plates and this method. The critical influence of ambient temperature on the inter-assay reproducibility of this method was established by testing samples over a range of temperatures between 20 degrees C and 40 degrees C.
Paul-Brent
Peta-Anne
PA
Australian Centre for Complementary Medicine Education and Research, University of Queensland and Southern Cross University, Brisbane, Queensland, Australia.
Cattley
Trudi N
TN
Myers
Stephen P
SP
Brooks
Lyndon
L
Cheras
Phillip A
PA
D000328:Adult; D001331:Automation; D001780:Blood Coagulation Tests; D004305:Dose-Response Relationship, Drug; D005260:Female; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000032:analysis*; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D015203:Reproducibility of Results; D012712:Serum Globulins; D013300:Streptokinase / Q000494:pharmacology; D013696:Temperature
D005343:Fibrinolytic Agents; D012712:Serum Globulins; D013300:Streptokinase